Hypospadias, when the urethra opens on the ventral side of the penis, is a common malformation seen in about 3 per 1,000 male births. It is a complex disorder associated with genetic and environmental factors and can be part of genetic syndromes. Mowat-Wilson syndrome (MWS) is a multiple congenital anomaly syndrome characterized by a distinct facial phenotype, Hirschsprung disease, microcephaly and mental retardation. It is caused by mutations in the zinc finger homeo box 1B gene, ZFHX1B (SIP1). To date, 68 deletion/mutation-positive cases have been reported. Genitourinary anomalies are common in MWS. Here we report that hypospadias is common in males with this syndrome. In 39 patients where this information was available, hypospadias was present in 46% of patients (18/39). In the 3 Italian male cases reported here, hypospadias was always present. MWS should be considered by endocrinologists in patients with hypospadias associated with developmental delays/mental retardation, in particular in the presence of a distinct facial phenotype.

Keywords:
Mowat-Wilson syndrome, genitourinary anomalies, Hypospadias, Craniofacial phenotype, Hirschsprung disease, Zinc finger homeo box 1B gene, ZFHX1B, ZFHX1B gene (SIP1)
1.
Mowat DR, Croaker GDH, Cass DT, Kerr BA, Chaitow J, Adès LC, Chia NL, Wilson M: Hirschsprung disease, microcephaly, mental retardation, and characteristic facial features: Delineation of a new syndrome and identification of a locus at chromosome 2q22–q23. J Med Genet 1998;35:617–623.
2.
Lurie IW, Supovitz KR, Rosenblum-Vos LS, Wulfsberg EA: Phenotypic variability of del(2)(q22–q23): Report of a case and review of the literature. Genet Counsel 1994;5:11–14.
3.
Wakamatsu N, Yasukazu Y, Kenichiro Y, Takao O, Nomura N, Taniguchi H, Kitoh H, Mutoh N, Yamanaka T, Mushiake K, Kato K, Sonta S, Nagaya M: Mutations in SIP1, encoding Smad interacting protein-1, cause a form of Hirschsprung disease. Nat Genet 2001;27:369–370.
4.
Cacheux V, Dastot-Le Moal F, Kääriäinen H, Bondurand N, Rintala R, Boissier B, Wilson M, Mowat D, Goossens M: Loss-of-function mutations in SIP1 Smad interacting protein 1 results in a syndromic Hirschsprung disease. Hum Mol Genet 2001;10:1503–1510.
5.
Zweier C, Albrecht B, Mitulla B, Behrens R, Beese M, Gillessen-Kaesbach G, Rott HD, Rauch A: ‘Mowat-Wilson’ syndrome with and without Hirschsprung disease is a distinct, recognizable multiple congenital anomalies-mental retardation syndrome caused by mutations in the zinc finger homeo box 1B gene. Am J Med Genet 2002;108:177–181.
6.
Garavelli L, Donadio A, Zanacca C, Della Giustina E, Bertani G, Albertini G, Zollino M, Rauch A, Banchini G, Neri G: Hirschsprung disease, mental retardation, characteristic facial features and mutation in the gene ZFHX1B (SIP1): Confirmation of the Mowat-Wilson syndrome. Am J Med Genet 2003;116A:385–388.
7.
Amiel J, Espinosa-Parrilla Y, Steffann J, Pelet A, Gosset P, Choiset A, Tanaka H, Prieur M, Vekemans M, Munnich A, Lyonnet S: Large scale deletions and SMADIP1 truncating mutations in syndromic Hirschsprung disease with involvement of midline structures. Am J Hum Genet 2001;69:1370–1377.
8.
Yamada K, Yamada Y, Nomura N, Miura K, Wakako R, Hayakawa C, Matsumoto A, Kumagai T, Yoshimura I, Miyazaki S, Kato K, Sonta S, Ono H, Yamanaka T, Nagaya N, Wakamatsu N: Nonsense and frameshift mutations in ZFHX1B, encoding Smad interacting protein 1, cause a complex developmental disorder with a great variety of clinical features. Am J Hum Genet 2001;69:1178–1185.
9.
Mowat DR, Wilson MJ, Goossens M: Mowat-Wilson syndrome J Med Genet 2003;40:305–310.
10.
Wilson M, Mowat D, Dastot-LeMood F: Further delineation of the phenotype associated with heterozygous mutation in ZFHX1B. Am J Med Genet 2003;119A:257–265.
11.
Zweier C, Temple IK, Beemer F, Zackai E, Lerman-Sagie T, Weschke B, Anderson CE, Rauch A: Characterisation of deletions of the ZFHX1B region and genotype-phenotype analysis in Mowat-Wilson syndrome. J Med Genet 2003;40:601–605.
12.
Cerruti-Mainardi P, Pastore G, Zweier C, Rauch A: Mowat-Wilson syndrome and mutation in the zinc finger homeo box 1B gene: A well-defined clinical entity. J Med Genet 2004;41:e16 (http://www.jmedgenet.com/cgi/content/full/41/2/e16), DOI: 10.1136/img 2003.009548
13.
Kääriäinen H, Wallgren-Pettersson C, Clarke A, Pihko H, Taskinen H, Rintala R: Hirschsprung disease, mental retardation and dysmorphic facial features in five unrelated children. Clin Dysmorphol 2001;10:157–163.
14.
Nagaya M, Kato J, Niimi N: Clinical features of a form of Hirschsprung’s disease caused by a novel genetic abnormality J Pediatr Surg 2002;37:1117–1122.
15.
Sztriha L, Espinosa-Parrilla Y, Gururaj A, Amiel J, Lyonnet S, Gerarni S, Johansen JG: Frameshift mutation of the zinc finger homeo box 1B gene in syndromic corpus callosum agenesis (Mowat-Wilson syndrome). Neuropediatrics 2003;34:322–325.
16.
Ishihara N, Yamada K, Yamada Y, Miura K, Kato J, Kuwabara N, Hara Y, Kabayashi Y, Hoshino K, Nomura Y, Mimaki M, Ohya K, Matsushima M, Nitta H, Tanaka K, Segawa M, Ohki T, Ezoe T, Kumagai T, Onuma A, Kurada T, Yoneda M, Yamanaka T, Saeki M, Segawa M, Saji T, Nagaya M, Wakamatsu N: Clinical and molecular analysis of Mowat-Wilson syndrome associated with ZFH1B mutations and deletions at 2q22–24.1 J Med Genet 2004;41:387–393.
17.
Frankenburg WK, Dodds JB, Archer P, Shapiro H, Bresnick B: The Denver II: A major revision restandardization of the Denver Developmental Screening Test. Pediatrics 1992;89:91–97.
18.
Goldberg RB, Shprintzen RJ: Hirschsprung megacolon and cleft palate in two sibs. J Craniofac Genet Dev Biol 1981;1:185–189.
19.
Davenport M, Taitz LS, Dickson JAS: The Kaufman-McKusick syndrome: Another association. J Pediatr Surg 1989;24:1192–1194.
20.
Aylsworth AS, Lin AE, Friedman PA: Nager acrofacial dysostosis: Male to male transmission in two families. Am J Med Genet 1991;41:83–88.
21.
Passarge E: Whither polygenic inheritance: Mapping Hirschsprung disease. Nat Genet 1993;4:325–326.
22.
Edery P, Attie T, Amiel J, Pelet A, Eng C, Hofstra RM, Martelli H, Bidaud C, Munnich A, Lyonnet S: Mutations of the endothelin-3 gene in the Waardenburg-Hirschsprung disease (Shah-Waardenburg syndrome). Nat Genet 1996;12:442–444.
23.
Islek I, Kucukoduk S, Erkan D, Bernay F, Kalayci AG, Gork S, Ka B, Gurses N: Bardet-Biedl syndrome: Delayed diagnosis in a child with Hirschsprung disease. Clin Dysmorphol 1996;5:271–273.
24.
Brooks AS, Breuning MH, Osinga J, Smagt JJ, Catsman CE, Buys CHCM, Meijers C, Hofstra RMW: A consanguineous family with Hirschsprung disease, microcephaly and mental retardation (Goldberg-Shprintzen syndrome). J Med Genet 1999;36:485–489.
25.
Parisi MA, Kapur RP: Genetics of Hirschsprung disease. Curr Opin Pediatr 2000;12:610–617.
26.
Dolk H, Vrijheid M, Scott JES, Addor MC, Botting B, de Vigan C, de Walle H, Garne E, Loane M, Pierini A, Garcia-Minaur S, Physick N, Tenconi R, Wiesel A, Calzolari E, Stone D: Toward the effective surveillance of hypospadias. Environ Health Perspect 2004;112 (http://ehp.niehs.nih.gov/members/2003/6398/6398.html), DOI: 10.1289/ehp.6398 available via
https://doi.org/
27.
Verschueren K, Remacle JE, Collart C, Kraft H, Baker BS, Tylzanowski P, Nelles L, Wuytens G, Su MT, Bodmer R, Smith JC, Huylebroeck D: SIP1, a novel zinc finger/homeodomain repressor, interacts with smad proteins and binds to 55-CACCT sequences in candidate target genes. J Biol Chem 1999;274:20489–20498.
28.
Watanabe M, Whitman M: The role of transcription factors involved in TGFβ superfamily signaling during development. Cell Mol Biol 1999;45:537–543.
29.
Shi Y: Structural insights on Smad function in TGFβ signaling. Bioessays 2001;23:223–232.
© 2005 S. Karger AG, Basel
2005
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.